Related Experiment Video
Updated: Aug 13, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Risperidone in the treatment of psychotic depression
1Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Risperidone, primarily for schizophrenia, shows promise as a monotherapy for treating psychotic depression. Further controlled studies are needed to confirm its efficacy in managing this complex mood disorder.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Risperidone is an atypical antipsychotic mainly prescribed for schizophrenia.
- Emerging evidence suggests potential applications in affective disorders.
Observation:
- A case study involving a patient diagnosed with psychotic depression is presented.
- The patient received risperidone as a standalone treatment.
Findings:
- Successful treatment of psychotic depression was achieved with risperidone monotherapy.
- This case highlights risperidone's potential efficacy in this specific psychiatric condition.
Implications:
- Risperidone may be a viable monotherapeutic option for psychotic depression.
- Controlled clinical trials are essential to validate these findings and establish treatment guidelines.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications

